Crossmark

Thrice daily consumption of a novel, premeal shot containing a low dose of whey protein increases time in euglycemia during 7 days of free-living in individuals with type 2 diabetes

Crossref DOI link: https://doi.org/10.1136/bmjdrc-2022-002820

Published Online: 2022-05-26

Published Print: 2022-05

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Smith, Kieran https://orcid.org/0000-0001-7275-4379
Taylor, Guy S https://orcid.org/0000-0002-5207-1498
Brunsgaard, Lise H

Walker, Mark

Bowden Davies, Kelly A

Stevenson, Emma J

West, Daniel J https://orcid.org/0000-0003-2246-4925
Clinical Trials ^BETA

Clinical trials referenced in this document:

isrctn17563146 at ISRCTN.org

Documents that mention this clinical trial

Thrice daily consumption of a novel, premeal shot containing a low dose of whey protein increases time in euglycemia during 7 days of free-living in individuals with type 2 diabetes
https://doi.org/10.1136/bmjdrc-2022-002820
Funding

Funding for this research was provided by:

Dexcom, Inc. (N/A)

Arla Foods Ingredients Group (BH172513)
License Information

License valid from 2022-05-25

Document is current

Any future updates will be listed below